Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Department of Immunology and Histocompatibility, |
RCV000768688 | SCV000900058 | pathogenic | Hereditary angioedema type 1 | criteria provided, single submitter | clinical testing | The c.106_107delAG (p.Ser36Phefs*21) variant has been previously reported in association with hereditary angioedema in the literature (Verpy et al., 1996) and in HAE database (http://hae.enzim.hu/detail.php?id=17). It causes interruption of the reading frame by the formation of a termination codon (*21aa) which results in a truncated protein. It was detected by our laboratory in 1 male patient with C1-INH HAE Type I. It has never been detected in approximately 120000 individuals of the Exome Aggregation Consortium (ExAC), indicating that it is not a common variant. Taking all the above into account and according to ACMG Guidelines (Criteria: PVS1, PM2, PM4, PP4) the variant is considered pathogenic. | |
Fulgent Genetics, |
RCV005049683 | SCV005683780 | pathogenic | Hereditary angioedema type 1; C1 inhibitor deficiency | 2024-06-13 | criteria provided, single submitter | clinical testing |